These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11014130)

  • 21. Anomalous pancreaticobiliary ductal junction without bile duct dilatation in gallbladder cancer.
    Elnemr A; Ohta T; Kayahara M; Kitagawa H; Yoshimoto K; Tani T; Shimizu K; Nishimura G; Terada T; Miwa K
    Hepatogastroenterology; 2001; 48(38):382-6. PubMed ID: 11379314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limitations in improving detection of pancreatic adenocarcinoma.
    Mendieta Zerón H; García Flores JR; Romero Prieto ML
    Future Oncol; 2009 Jun; 5(5):657-68. PubMed ID: 19519205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to define patients at high risk for pancreatic cancer.
    Yamaguchi K
    Pancreatology; 2011; 11 Suppl 2():3-6. PubMed ID: 21464580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cancer of the pancreas, gallbladder and bile ducts].
    Ghadirian P; Simard A; Baillargeon J
    Union Med Can; 1986 Jun; 115(6):409-15. PubMed ID: 3739057
    [No Abstract]   [Full Text] [Related]  

  • 25. Carcinoma of the gallbladder.
    Frommer D
    Gastroenterology; 1982 Mar; 82(3):602. PubMed ID: 10336330
    [No Abstract]   [Full Text] [Related]  

  • 26. Trypsinogen activation peptide (TAP) expression in gallbladder bile identifies bilio-pancreatic carcinoma.
    Brockmann JG; Hernandez CA; Emparan C; Wolters H; Haier J; Dietl KH; Senninger NJ
    Anticancer Res; 2003; 23(2A):819-25. PubMed ID: 12820306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic cancer in Israel: the epidemiology, possibilities of prevention, early detection and screening.
    Rozen P; Liphshitz I; Rosner G; Barchana M; Lachter J; Pel S; Shohat T; Santo E;
    Isr Med Assoc J; 2009 Dec; 11(12):710-3. PubMed ID: 20166335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is early diagnosis of pancreatic cancer fiction? Surveillance of individuals at high risk for pancreatic cancer.
    Harinck F; Poley JW; Kluijt I; Fockens P; Bruno MJ;
    Dig Dis; 2010; 28(4-5):670-8. PubMed ID: 21088419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of benign inflammatory disease in patients undergoing Whipple procedure for clinically suspected carcinoma: a single-institution experience.
    Kennedy T; Preczewski L; Stocker SJ; Rao SM; Parsons WG; Wayne JD; Bell RH; Talamonti MS
    Am J Surg; 2006 Mar; 191(3):437-41. PubMed ID: 16490563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical strategies in patients with gallbladder cancer: nihilism to optimism.
    Sikora SS; Singh RK
    J Surg Oncol; 2006 Jun; 93(8):670-81. PubMed ID: 16724356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pancreatic cancer linked to life style and genome].
    Sand J; Räty S; Nordback I
    Duodecim; 2009; 125(7):759-65. PubMed ID: 19432081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection as a risk factor for gallbladder cancer.
    Kumar S; Kumar S; Kumar S
    J Surg Oncol; 2006 Jun; 93(8):633-9. PubMed ID: 16724347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
    Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
    Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inherited genetics of pancreatic cancer and prospects for secondary screening.
    Vitone LJ; Greenhalf W; McFaul CD; Ghaneh P; Neoptolemos JP
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):253-83. PubMed ID: 16549327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High risk of bile duct carcinogenesis after primary resection of a congenital biliary dilatation.
    Tsuchida A; Kasuya K; Endo M; Saito H; Inoue K; Nagae I; Aoki T; Koyanagi Y
    Oncol Rep; 2003; 10(5):1183-7. PubMed ID: 12883678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pooled analysis of second primary pancreatic cancer.
    Shen M; Boffetta P; Olsen JH; Andersen A; Hemminki K; Pukkala E; Tracey E; Brewster DH; McBride ML; Pompe-Kirn V; Kliewer EV; Tonita JM; Chia KS; Martos C; Jonasson JG; Colin D; Scélo G; Brennan P
    Am J Epidemiol; 2006 Mar; 163(6):502-11. PubMed ID: 16421239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
    Bergquist A; Broomé U
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term results of treatment for pancreaticobiliary maljunction without bile duct dilatation.
    Ohuchida J; Chijiiwa K; Hiyoshi M; Kobayashi K; Konomi H; Tanaka M
    Arch Surg; 2006 Nov; 141(11):1066-70. PubMed ID: 17116798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gallbladder cancer: a review].
    de Aretxabala X; Roa I; Burgos L
    Rev Med Chil; 1996 Jun; 124(6):732-9. PubMed ID: 9041732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular markers of early pancreatic cancer.
    Goggins M
    J Clin Oncol; 2005 Jul; 23(20):4524-31. PubMed ID: 16002843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.